Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].

Baxter, Roger; Eaton, Abigail; Hansen, John; Aukes, Laurie; Caspard, Herve; Ambrose, Christopher S

Baxter, Roger; Eaton, Abigail; Hansen, John; Aukes, Laurie; Caspard, Herve; Ambrose, Christopher S.

Afiliación

Baxter R; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Eaton A; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Hansen J; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States. Electronic address: john.hansen@kp.org.
Aukes L; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Caspard H; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, United States.
Ambrose CS; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, United States.

Vaccine ; 35(23): 3152, 2017 05 25.

Article en En | MEDLINE | ID: mdl-28457674

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google